BPC-157 has demonstrated healing effects in models of inflammatory bowel disease, gastric ulceration caused by non-steroidal anti-inflammatory drugs, short bowel syndrome, and intestinal fistulas
BPC 157 research protocol: Targeting Angiogenesis and Nitric Oxide's Cytotoxic and [PMID: 41155565] Laboratory literature summary: BPC 157 research protocol: Targeting Angiogenesis and Nitric Oxide's Cytotoxic and Damaging Actions, but Maintaining, Promoting, or
At 72 weeks, participants on 15mg lost an average of 22.5% body weight compared to 2.4% in the placebo group
Zonulin antagonist, larazotide (AT1001), as an adjuvant treatment for multisystem inflammatory syndrome in children: a case series
At Perfect B in Doral, every BPC-157 protocol is individualized at a licensed APRN intake before any medication is prescribed or dispensed
In addition, Xi'an Sonwu manages every aspect and minimizes expenses to ensure that clients receive reasonably priced goods